Revlimid is a medicine used to treat certain types of cancer, like multiple myeloma and mantle cell lymphoma. It helps the body fight the cancer cells. It's taken as a pill, usually once a day.
Every report comes from a Lived member, sent anonymously.
Have you tried Revlimid (Lenalidomide) for Multiple Myeloma?
Lenalidomide, sold under the brand name Revlimid and also available as generic capsules, is an oral cancer medicine used for several blood cancers in adults. Its main use is multiple myeloma, a cancer of plasma cells in the bone marrow. There it is given together with dexamethasone, a steroid, and it is also taken on its own as long-term maintenance treatment after a stem cell transplant that uses a person's own cells, to help keep the myeloma under control. It is also approved for a specific form of myelodysplastic syndromes (MDS), bone marrow disorders in which the marrow does not make enough healthy blood cells. Lenalidomide is used when lower-risk MDS has a deletion 5q abnormality (part of chromosome 5 is missing) and causes anemia that needs regular red blood cell transfusions. In lymphomas, cancers of white blood cells called lymphocytes, it is used for mantle cell lymphoma that has returned or worsened after two earlier treatments, one of which included bortezomib (Velcade, an injected cancer medicine), and together with rituximab (an antibody treatment) for follicular or marginal zone lymphoma that has been treated before. It is not recommended for chronic lymphocytic leukemia outside of clinical trials.
Lenalidomide is a close chemical relative of thalidomide and belongs to a group sometimes called immunomodulatory drugs. Inside cells it binds a protein called cereblon, which is part of the machinery that tags other proteins for disposal. With the drug attached, that machinery breaks down proteins that certain blood cancer cells depend on to survive. The result works on two fronts. Some cancer cells stop multiplying and die directly, and the immune system is stimulated, with more active T cells and natural killer cells that can attack cancer cells. Combining it with dexamethasone in myeloma, or with rituximab in lymphoma, strengthens these effects. The same activity on dividing cells explains why it also lowers healthy blood counts.
Lenalidomide comes as capsules taken by mouth once a day, at about the same time each day, with or without food. Swallow the capsules whole with water; do not open, break or chew them, and handle them as little as possible. If powder gets on the skin, wash it off with soap and water. It is usually taken in 28-day cycles. For active myeloma and for lymphoma, a common pattern is 21 days on the medicine followed by 7 days off. As maintenance after a transplant, it is often taken every day of the cycle at a lower dose. For deletion 5q MDS, it is usually taken every day without a break. The starting dose depends on the condition and on kidney function, and the care team often lowers the dose or pauses treatment when blood counts drop or side effects become hard to manage. If a dose is missed and less than 12 hours have passed, take it when remembered. If more than 12 hours have passed, skip it and take the next dose at the usual time; never take two doses together. The medicine is dispensed only by specially certified pharmacies (see Interactions & Warnings), and it should never be shared with anyone.
Diarrhea, constipation, tiredness, rash, itching, nausea, muscle cramps, swelling in the legs or hands and trouble sleeping are common. Many people also get colds and other upper respiratory infections more often. Lenalidomide lowers white blood cells and platelets in most people, which raises the risk of infection and bleeding. This is why blood counts are checked often, especially in the first few months. Contact the care team right away about a fever, chills, a sore throat or other signs of infection, or about unusual bruising, nosebleeds or bleeding gums. Blood clots in the legs or lungs, and less often heart attacks and strokes, are more common on lenalidomide, especially in myeloma treatment that includes dexamethasone. Most people also take a blood thinner to lower this risk, chosen according to their own clot risk. A clot in an arm or leg usually causes swelling in that limb along with pain, tenderness or warmth, which is different from the general mild swelling of the legs or hands described above. Get emergency care for chest pain, shortness of breath, or this kind of swelling in an arm or leg. Call 911 for sudden weakness or numbness on one side, trouble speaking or a sudden severe headache. Less often, lenalidomide affects the liver or causes a severe skin or allergic reaction. Tell the care team right away about yellowing of the skin or eyes, dark urine, or a rash that blisters or peels, especially with fever. Swelling of the lips, tongue or throat, or trouble breathing or swallowing, needs emergency help.
Lenalidomide can cause serious birth defects or the death of an unborn baby, because it is related to thalidomide. It must not be taken during pregnancy. For this reason it is available only through a restricted program called the Lenalidomide REMS (Risk Evaluation and Mitigation Strategy), which certifies the prescriber and pharmacy and requires the patient to sign an agreement to follow its rules. Anyone who could become pregnant needs two negative pregnancy tests before starting and regular tests during treatment. They must use two methods of birth control at the same time, one highly effective method (an intrauterine device or IUD, hormonal birth control, tubal ligation or a partner's vasectomy) plus one additional method such as a condom, diaphragm or cervical cap, or not have heterosexual sex at all, starting 4 weeks before treatment and continuing through any breaks and for 4 weeks after the last dose. A missed period, unusual bleeding, failed birth control or any possibility of pregnancy means stopping the medicine and calling the prescriber right away. The drug also passes into semen. Men taking it must use a latex or synthetic condom during any sexual contact with a partner who is or could become pregnant, even after a vasectomy, and must not donate sperm, during treatment and for 4 weeks afterward. No one taking lenalidomide should donate blood during treatment or for 4 weeks after stopping. Breastfeeding is not recommended. In myeloma, lenalidomide raises the chance of developing a second cancer, notably acute myeloid leukemia (AML) or MDS, particularly when combined with melphalan (a chemotherapy drug) or used after a transplant. For most people its benefit in controlling myeloma outweighs this risk, but it is a trade-off worth discussing. Tell the care team about all medicines. Estrogen-containing treatments, such as birth control pills or hormone therapy, and drugs that boost red blood cell production (erythropoiesis-stimulating agents such as epoetin) further increase clot risk. People taking digoxin, a heart rhythm medicine, may need their levels checked. Lenalidomide should not be taken by people who have had a severe allergic reaction to it, or a severe rash with thalidomide. The capsules contain lactose, which is worth mentioning to the pharmacist for anyone who is lactose intolerant.
Lenalidomide involves regular blood tests: blood counts weekly or every two weeks at first and then about monthly, along with periodic checks of liver and thyroid function and, for people who could become pregnant, pregnancy tests. Dose reductions and short pauses are a normal part of treatment and do not mean it has failed. How long treatment lasts depends on the use. In myeloma it is usually continued as long as it keeps working and side effects are manageable, which can mean years. In large studies, maintenance after a transplant roughly doubled the time before myeloma returned and helped people live longer than no maintenance. People with deletion 5q MDS who benefit usually stop needing transfusions within about three months. In follicular and marginal zone lymphoma, it is given for a fixed course of up to 12 cycles. For people with myeloma who may have a stem cell transplant, early planning with a transplant center matters, because more than four cycles of lenalidomide can make it harder to collect enough stem cells. In lymphoma, some people notice tender, swollen lymph nodes, low fever or rash early in treatment, called a tumor flare, which can look like the cancer getting worse and should be reported.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Revlimid (Lenalidomide), what you've noticed, or ask the community a question.